bpc 157 vegf BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157 Peptide (Body Protection Compound)

A pharmacokinetic study in rats found that oral administration produced substantial plasma concentrations, with a maximum concentration of 2252 ng/mL and an elimination half-life of approximately 6.9 hours

This isnt just a joint healing peptide. Its a systemic compound affecting multiple organ systems through interconnected pathways

Early data and anecdotal reports indicate the half-life of BPC-157 might range anywhere from a few hours up to 24 hours, though precise data is limited

This may include: Rash Itching/swelling especially of the face, tongue and throat Severe dizziness Trouble breathing Storage Store at controlled room temperature